Visualisation of transforming growth factor-β1, tissue kallikrein, and kinin and transforming growth factor-β receptors on human clear-cell renal carcinoma cells

Biological Chemistry

Volumn 386, Issue 4, 2005, Pages 375-382

  Moodley, Rumesha ^a   Snyman, Celia ^a   Odhav, Bharti ^a   Bhoola, Kanti D ^b  

^a DURBAN UNIVERSITY OF TECHNOLOGY   (South Africa)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

Carcinogenesis; Double immunolabelling; Kinin receptors B1 and B2; Transforming growth factor receptors type II (T RII) and III (T RIII)

Indexed keywords

G PROTEIN COUPLED RECEPTOR; KININ; KININOGEN; RHODOPSIN; TISSUE KALLIKREIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; BRADYKININ RECEPTOR; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY LABELING; ARTICLE; CARCINOGENESIS; CELL MEMBRANE; CELL PROLIFERATION; CELL TRANSFORMATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY DISTAL TUBULE; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; METASTASIS POTENTIAL; MITOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; ADENOCARCINOMA; COMPARATIVE STUDY; ENZYMOLOGY; KIDNEY TUMOR; METABOLISM; PATHOLOGY;

ADENOCARCINOMA, CLEAR CELL; HUMANS; KIDNEY NEOPLASMS; RECEPTORS, BRADYKININ; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TISSUE KALLIKREINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 25144446869     PISSN: 14316730     EISSN: 14316730     Source Type: Journal    
DOI: 10.1515/BC.2005.045     Document Type: Article

References (42)

1. Akita, K., Okuno, M., Enya, M., Imai, S., Moriwaki, H., Kawada, N., Suzuki, Y., and Kojima, S. (2002). Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-β. Gastroentrology 123, 352-364.
2. Ando, T., Okuda, S., Yanagida, T., and Fujishima, M. (1998). Localization of TGF-β and its receptors in the kidney. Miner. Electrolyte Metab. 24, 149-153.
3. Barrack, E.R. (1997). TGF-β in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31, 61-70.
4. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44, 1-80.
5. Bhoola, K., Ramsaroop, R., Plendl, J., Cassim, B., Dlamini, Z., and Naicker, S. (2001). Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem. 382, 77-89.
6. Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890.
7. Carroll, V.A. and Binder, B.R. (1999). The role of the plasminogen activation system in cancer. Semin. Thromb. Hemost. 12, 211-217.
8. Clements, J.A. (1994). The human kallikrein gene family: a diversity of expression and function. Mol. Cell. Endocrinol. 99, C1-C6.
9. Clements, J., Hooper, J., Dong, Y., and Harvey, T. (2001). The expanded human kallikrein (KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biol. Chem. 382, 5-14.
10. Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab Sci. 41, 265-312.
11. Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, I., and Obiezu, C.V. (2000). The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab. 11, 54-60.
12. Dlamini, Z., Raidoo, D., and Bhoola, K. (1999). Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Immunopharmacology 43, 303-310.
13. el-Dahr, S.S., Figueroa, C.D., Gonzalez, C.B., and Müller-Esterl, W. (1997). Ontogeny of bradykinin B2 receptors in the rat kidney: implications for segmental nephron maturation. Kidney Int. 51, 739-749.
14. Figueroa, C.D., MacIver, A.G., Mackenzie, J.C., and Bhoola, K.D. (1988). Localization of immunoreactive kininogen and tissue kallikrein in the human nephron. Histochemistry 89, 437-442.
15. Govinden, R. and Bhoola, K.D. (2003). Geneology, expression, and cellular function of transforming growth factor-β. Pharmacol. Ther. 98, 257-265.
16. Haaseman, M., Figueroa, C.D., Henderson, L., Grigoriev, S., Abd Alla, S., Gonzalez, C.B., Dunia, I., Hoebeke, J., Jarnagin, K., Cartaud, J., Bhoola, K.D., and Müller-Esterl, W. (1994). Distribution of bradykinin B2 receptors in target cells of kinin action. Visualisation of the receptor proteins in A431 cells, neutrophils and kidney sections. Braz. J. Med. Biol. Res. 27, 1739-1756.
17. Lee-Chen, G.J., Liu, K.P., Lai, Y.C., Juang, H.S., Huang, S.Y., and Lin C.Y. (2004). Significance of the tissue kallikrein promoter and transforming growth factor-β1 polymorphisms with renal progression in children with vesicoureteral reflux. Kidney Int. 65, 1467-1472.
18. MacKay, K., Kondaiah, P., Danielpour, D., Austin, H.A., and Brown, P.D. (1990). Expression of transforming growth factor-β1 and -β2 in rat glomeruli. Kidney Int. 38, 1095-1100.
19. Massague, J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641.
20. Massague, J. (1992). Receptors for the TGF-β family. Cell 69, 1067-1070.
21. Massague, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-759.
22. Massague, J. and Chen, Y.G. (2000). Controlling TFG-β signaling. Genes Dev. 14, 627-644.
23. Menke, J.G., Borkowski, J.A., Bierilo, K.K., MacNeil, T., Derrick, A.W., Schneck, K.A., Ransom, R.W., Strader, C.D., Linemeyer, D.L., and Hess, J.F. (1994). Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 269, 21583-21586.
24. Naicker, S., Naidoo, S., Ramsaroop, R., Moodley, D., and Bhoola, K. (1999). Tissue kallikrein and kinins in renal disease. Immunopharmacology 44, 183-192.
25. Naidoo, S., Ramsaroop, R.T., Naidoo, Y., and Bhoola, K.D. (1996). Status of B2 receptors in acute renal transplant kidney. Immunopharmacology 33, 157-160.
26. Parada, D., Arciniegas E., Moreira, O., and Trujillo, E. (2004). Transforming growth factor-β2 and -β3 expression in carcinoma of the prostate. Arch. Esp. Urol. 57, 9399.
27. Peek, M., Moran, P., Mendoza, N., Wickramasinghe, D., and Kirchhofer, D. (2002). Unusual proteolytic activation of prohepatocyte growth factor by plasma kallikrein and coagulation factor XIa. J. Biol. Chem. 277, 47804-47809.
28. Rahn, H.P., Angermann, A., Hektor, T., Kloppinger, M., and Kemme, M. (1992). Expression of human salivary gland kallikrein in insect cells by a baculovirus vector. Agents Actions 38 (Suppl.), 66-73.
29. Ramsaroop, R., Naicker, S., Naicker, T., Naidoo S., and Bhoola, K.D. (1997). Tissue kallikrein in transplant kidney. Immunopharmacology 36, 255-261.
30. Rifkin, D.B. (1997). Cross-talking proteases and matrix in the control of growth factor action. Fibrinolysis Proteolysis 11, 3-9.
31. Rifkin, D.B., Tsuboi, R., and Mignatti, P. (1989). The role of proteases in matrix breakdown during invasion. Am. Rev. Respir. Dis. 140, 1112-1113.
32. Rifkin, D.B., Mazzieri, R., Munger, J.S., Noguera, I., and Song, J. (1999). Proteolytic control of growth factor availability. APMIS 107, 80-85.
33. Roberts, A.B. and Sporn, M.B. (1990). The transforming growth factor-β. In: Handbook of Experimental Pharmacology: Peptide Growth Factors and their Receptors, M.B. Sporn and A.B. Roberts, eds. (Berlin, Germany: Springer-Verlag), pp. 419-472.
34. Roberts, A.B., Anzono, M.A., Wakefield, L.M., Roche, N.S., Stern, D.F., and Sporn, M.B. (1985). Type-β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82, 119-123.
35. Roberts, R.A. and Gullick, W.J. (1989). Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis by expression of mutant ras oncogene. J. Cell Sci. 94, 527-535.
36. Shankland, S.J., Pippin, J., Pichler, R.H., Gordon, K.L., Friedman, S., Gold, L.I., Johnson, R.J., and Couser, W.G. (1996). Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int. 50, 116-124.
37. Sporn, M.B. and Roberts, A.B. (1990). TGF-β: problems and prospects. Cell Regul. 1, 876-882.
38. Song, Q., Wang, D.Z., Harley, R.A., Chao, L., and Chao, J. (1996). Cellular localisation of low molecular weight kininogen and bradykinin B2 receptor mRNAs in human kidney. Am. J. Physiol. 270, F919-F926.
39. Stravodimos, K., Constantinides, C., Manousakas, T., Pavlaki, C., Pantazopoulos, D., Glannopoulos, A., and Dimopoulos, C. (2000). Immunohistochemical expression of transforming growth factor-β1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinincopathological parameters. Anticancer Res. 20, 3823-3828.
40. Steiner, M.S. and Barrack, E.R. (1992). Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol. 6, 15-25.
41. Vandesande, F. (1983). Immunochemical double staining techniques. In: Immunohistochemistry, A.C. Cuello, ed. (New York, USA: John Wiley and Sons), pp. 257-273.
42. Yousef, G.M. and Diamandis, E.P. (2000). The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-13. Genomics 65, 184-194.